1. Home
  2. IPAR vs IRON Comparison

IPAR vs IRON Comparison

Compare IPAR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$95.96

Market Cap

2.9B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.64

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
IRON
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
IPAR
IRON
Price
$95.96
$69.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$116.60
$103.18
AVG Volume (30 Days)
206.1K
407.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.54%
N/A
EPS Growth
2.34
N/A
EPS
1.35
N/A
Revenue
$1,317,700,000.00
N/A
Revenue This Year
$3.86
N/A
Revenue Next Year
$7.89
$283.52
P/E Ratio
$71.58
N/A
Revenue Growth
21.26
N/A
52 Week Low
$77.21
$40.00
52 Week High
$142.50
$99.50

Technical Indicators

Market Signals
Indicator
IPAR
IRON
Relative Strength Index (RSI) 60.08 55.45
Support Level $92.30 $64.39
Resistance Level $98.64 $71.53
Average True Range (ATR) 2.97 3.18
MACD 0.87 0.23
Stochastic Oscillator 89.54 64.38

Price Performance

Historical Comparison
IPAR
IRON

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: